Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06974058) titled 'Study to Investigate the Health Benefits of a Quercetin/Curcumin-Based Supplement for Mild to Moderate Long COVID-19 Symptoms' on May 12.
Study Type: Interventional
Study Design:
Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Liaquat University of Medical & Health Sciences
Condition:
Long COVID
Intervention:
Dietary Supplement: Nasafytol(R) (Quercetin/Curcumin Supplement)...
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: June 15, 2025
Target Sample Size: 15
Countries of Recruitment:
Pakistan...